This emulsifying action ensures gentler fat clearance without damaging the surrounding tissue
With a total concentration of 5000mcg/mL (which works out to 50mcg per unit on a standard U-100 syringe), you would draw up 4 units
Cardiovascular Safety : The cardiovascular safety of tirzepatide has been evaluated and confirmed to date through a pre-specified meta-analysis of phase 2 and 3 randomized trials comparing tirzepatide with other placebo, insulin glargine, degludec, semaglutide, dulaglutide for a minimum of 26 weeks (including the GPGB, SURPASS 1,2,3,4,5, and J-mono studies) [67]
Pharmacokinetic, insulinotropic, and glucagonostatic properties of GLP-1 (736 amide) after subcutaneous injection in healthy volunteers
For example, a Cleveland Clinic study from June 2025, involving 7,881 participants, found that high-dose tirzepatide users lost 18.0% of their body weight in one year, semaglutide users lost 13.7%, and those who discontinued early (within three months) lost just 3.6%
Available from: GLP-1 medicines for weight loss and diabetes: what you need to know [Internet]